$150 Million Class Action Settlement by Drug Makers
A class action lawsuit which was filed against TAP Pharmaceutical Products Inc., Abbott Laboratories and Takeda Pharmaceutical Co. Ltd., alleged a fraudulent scheme to market, sell and distribute Lupron resulting in overpayment for the drug, was agreed to be settled for $150 million.
The lawsuit alleged that the defendants engaged in a scheme to increase market share by inflating the average wholesale price of Lupron, providing free drugs to physicians and instructing them on how to bill insurers as if they had purchased the drugs, plus other questionable inducements.
Filed under Class Action, General Law, Settlements
You may also like to read
- $150 Million Class Action Settlement by Three Drug Makers
- Class Action Lawsuit Settlement for $70 Million by GlaxoSmithKline
- $10 Million Class Action Settlement against German Drugmaker Bayer
- $7.75 Million To Be Paid To Brooks Automation Under Securities Class Action Settlement
- $30 Million Class Action Lawsuit Settlement by Martha Stewart
- De Beers, World's No. 1 Diamond Supplier Agreed to Pay $250 Million in Price Fixing Settlement
- GSK in Class Action Danger Over Anti-depressant Drug Seroxat
- Five Drug Companies Will be Sued For Alleged Overcharging by South Carolina Attorney General
- 50$ Million Class Action Lawsuit Approved Against Pfizer
- Philadelphia based drug maker faces lawsuits
